Furthermore, more recent research has revealed the link between LECT2 and the development of multiple immunological diseases such as sepsis (22–24), atherosclerosis (13, 25–27), osteoporosis (28, 29), arthritis (30–33), diabetes (10–12, 34), atopic dermatitis (35), and non-alcoholic steatohepatitis (NASH) (7, 8). Here, LECT2 is linked to atopic eczema.